Display options
Share it on

United European Gastroenterol J. 2020 Oct;8(8):878-885. doi: 10.1177/2050640620944720. Epub 2020 Jul 23.

The microbiome in pancreatic diseases: Recent advances and future perspectives.

United European gastroenterology journal

Christoph Ammer-Herrmenau, Nina Pfisterer, Mark Fj Weingarten, Albrecht Neesse

Affiliations

  1. Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Centre Goettingen, Goettingen, Germany.

PMID: 32703080 PMCID: PMC7707879 DOI: 10.1177/2050640620944720

Abstract

The human microbiota exerts multiple physiological functions such as the regulation of metabolic and inflammatory processes. High-throughput sequencing techniques such as next-generation sequencing have become widely available in preclinical and clinical settings and have exponentially increased our knowledge about the microbiome and its interaction with host cells and organisms. There is now emerging evidence that microorganisms also contribute to inflammatory and neoplastic diseases of the pancreas. This review summarizes current clinical and translational microbiome studies in acute and chronic pancreatitis as well as pancreatic cancer and provides evidence that the microbiome has a high potential for biomarker discovery. Furthermore, the intestinal and pancreas-specific microbiome may also become an integrative part of diagnostic and therapeutic approaches of pancreatic diseases in the near future.

Keywords: 16S rRNA sequencing; Pancreatic cancer; metagenomic sequencing; microbiome; pancreatitis

References

  1. Nature. 2019 Oct;574(7777):264-267 - PubMed
  2. United European Gastroenterol J. 2016 Oct;4(5):697-705 - PubMed
  3. BMC Microbiol. 2019 Feb 18;19(1):42 - PubMed
  4. Pancreatology. 2016 Sep-Oct;16(5):698-707 - PubMed
  5. Br J Surg. 2014 Dec;101(13):1644-56 - PubMed
  6. Gut. 2018 Jan;67(1):120-127 - PubMed
  7. CA Cancer J Clin. 2019 Jan;69(1):7-34 - PubMed
  8. Cancer Causes Control. 2017 Sep;28(9):959-969 - PubMed
  9. J Hepatobiliary Pancreat Sci. 2015 Apr;22(4):316-21 - PubMed
  10. Cancer Res. 2014 Jun 1;74(11):2913-21 - PubMed
  11. Science. 2020 May 29;368(6494):973-980 - PubMed
  12. Science. 2018 Jan 5;359(6371):97-103 - PubMed
  13. J Gastroenterol. 2019 Apr;54(4):347-358 - PubMed
  14. Science. 2018 Jan 5;359(6371):91-97 - PubMed
  15. Gastroenterology. 2018 Mar;154(4):1096-1101 - PubMed
  16. Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1353-1359 - PubMed
  17. Hepatobiliary Pancreat Dis Int. 2018 Oct;17(5):456-460 - PubMed
  18. PeerJ. 2015 Nov 05;3:e1373 - PubMed
  19. Cancer Discov. 2018 Apr;8(4):403-416 - PubMed
  20. Am J Surg. 2010 Jul;200(1):111-7 - PubMed
  21. Cancer Med. 2020 Jan;9(2):797-806 - PubMed
  22. Nature. 2012 Jun 13;486(7402):207-14 - PubMed
  23. Cell. 2019 Aug 8;178(4):795-806.e12 - PubMed
  24. ISME J. 2017 Apr;11(4):841-852 - PubMed
  25. Gut. 2012 Apr;61(4):582-8 - PubMed
  26. Pancreatology. 2018 Jun;18(4):379-385 - PubMed
  27. Chin Med J (Engl). 2020 Jan 20;133(2):212-220 - PubMed
  28. Nature. 2010 Mar 4;464(7285):59-65 - PubMed
  29. Nat Rev Genet. 2017 Nov;18(11):690-699 - PubMed
  30. Science. 2018 Jan 5;359(6371):104-108 - PubMed
  31. Gut. 2013 Dec;62(12):1764-70 - PubMed
  32. J Oral Microbiol. 2019 Jan 28;11(1):1563409 - PubMed
  33. Gastroenterology. 2019 Mar;156(4):1010-1015 - PubMed
  34. Sci Rep. 2017 Mar 03;7:43640 - PubMed
  35. Nat Rev Microbiol. 2018 Jul;16(7):410-422 - PubMed
  36. Science. 2017 Sep 15;357(6356):1156-1160 - PubMed

Substances

MeSH terms

Publication Types